Nutraceuticals

Hugo Ehrnreich
Additional contact information
Hugo Ehrnreich: Datamonitor Consumer Markets Practice Area

Chapter Chapter 16 in Brand Medicine, 2001, pp 255-273 from Palgrave Macmillan

Abstract: Abstract Ever since the emergence of terms such as ‘nutraceuticals’, ‘food as medicine’ and ‘functional foods’, the food and pharmaceutical industries have been mesmerized by the promise of lucrative premium branded revenues on the boundary between their respective industries. However, finding the right formula for turning this vision into reality is proving a difficult task. Indeed, although individual cases of success such as Yakult can be found, the results from the bulk of the first major initiatives in this sector have been ambiguous at best. A series of high-profile initiatives, such as Raisio/McNeil’s Benecol range of cholestrol-lowering products, have either failed to meet investors’ initial (high) expectations or, like the Kellogg Company’s Ensemble range, have been withdrawn following a lack of consumer interest.

Keywords: Energy Drink; Health Claim; Breakfast Cereal; Consumer Interest; Consumer Education (search for similar items in EconPapers)
Date: 2001
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-52251-0_17

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230522510

DOI: 10.1057/9780230522510_17

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().